Eldecalcitol
- Generic Name
- Eldecalcitol
- Drug Type
- Small Molecule
- Chemical Formula
- C30H50O5
- CAS Number
- 104121-92-8
- Unique Ingredient Identifier
- I2JP8UE90H
- Background
Eldecalcitol (ED-71), a vitamin D analog, is a more potent inhibitor of bone resorption than alfacalcidol in an estrogen-deficient rat model of osteoporosis. Eldecalcitol, effectively and safely increased lumbar and hip bone mineral density (BMD) in osteoporotic patients who also received vitamin D3 supplementation.
- Indication
Investigated for use/treatment in osteoporosis.
Clinical Intervention of Idecalcitol Combined With Whey Protein Powder and Exercise for Sarcopenia
- Conditions
- Sarcopenia
- Interventions
- First Posted Date
- 2024-08-05
- Last Posted Date
- 2024-08-05
- Lead Sponsor
- Zhejiang Provincial People's Hospital
- Target Recruit Count
- 450
- Registration Number
- NCT06537115
- Locations
- 🇨🇳
The First People's Hospital of Chun'an County, Hangzhou, Zhejiang, China
🇨🇳Dinghai Central Hospital of Zhoushan City, Zhoushan, Zhejiang, China
🇨🇳Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China
A Study on the Prevention and Treatment of GIOP With Eldecalcitol
- Conditions
- OsteoporosisRheumatoid ArthritisOsteopenia
- Interventions
- First Posted Date
- 2024-04-25
- Last Posted Date
- 2024-04-25
- Lead Sponsor
- Chinese SLE Treatment And Research Group
- Target Recruit Count
- 314
- Registration Number
- NCT06385093
- Locations
- 🇨🇳
Beijing Luhe hospital, Capital Medical University, Beijing, Beijing, China
🇨🇳Peking Union Medical College Hospital, Beijing, Beijing, China
🇨🇳Beijing Shunyi hospital, Beijing, Beijing, China
Eldecalcitol and Calcitriol in Postmenopausal Women With Low Bone Mineral Density or Mild Osteoporosis
- Conditions
- Low Bone Mineral DensityPostmenopausal Osteoporosis
- Interventions
- First Posted Date
- 2023-06-13
- Last Posted Date
- 2024-05-16
- Lead Sponsor
- Shanghai Jiao Tong University Affiliated Sixth People's Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT05902078
- Locations
- 🇨🇳
Zhejiang Provincial People's Hospital, Hangzhou, China
🇨🇳Huai 'an First People's Hospital, Huai'an, China
🇨🇳Shanghai Pudong New Area Punan Hospital, Shanghai, China
Comparison of Efficacy of Denosumab With Eldecalcitol or Native Vitamin D in Postmenopausal Women With Osteoporosis.
- Conditions
- Osteoporosis in Postmenopausal Women
- Interventions
- First Posted Date
- 2023-06-01
- Last Posted Date
- 2024-02-21
- Lead Sponsor
- Xi'an Honghui Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT05884372
- Locations
- 🇨🇳
Zeng,Yuhong, Xi'an, China
Post-Marketing Drug Intensive Monitoring Surveillance of EDIROL in Patients With Postmenopausal Osteoporosis
- Conditions
- Postmenopausal Osteoporosis
- First Posted Date
- 2022-06-27
- Last Posted Date
- 2022-06-27
- Lead Sponsor
- Chugai Pharmaceutical
- Target Recruit Count
- 1000
- Registration Number
- NCT05433207
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China
Bioequivalence Study of Eldecalcitol Soft Capsule in Healthy Chinese Subjects
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2022-06-06
- Last Posted Date
- 2022-06-06
- Lead Sponsor
- The Affiliated Hospital of Qingdao University
- Target Recruit Count
- 58
- Registration Number
- NCT05406050
- Locations
- 🇨🇳
The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
The Effectiveness of Eldecalcitol in the Bisphosphonate Non-respondered-patients With Osteoporosis
- First Posted Date
- 2014-12-03
- Last Posted Date
- 2021-09-21
- Lead Sponsor
- Shinshu University
- Target Recruit Count
- 100
- Registration Number
- NCT02306187
- Locations
- 🇯🇵
Yukio Nakamura, Matsumoto, Nagano, Japan
Eldecalcitol for GLucocorticoid Induced OsteopoRosIs Versus Alfacalcidol
- First Posted Date
- 2013-11-01
- Last Posted Date
- 2014-08-06
- Lead Sponsor
- e-GLORIA trial Protocol Review Committee
- Target Recruit Count
- 400
- Registration Number
- NCT01974167
- Locations
- 🇯🇵
Nara Hospital Kinki University Faculty of Medicine, Ikoma, Nara, Japan
A New Active Vitamin D, ED-71 for Osteoporosis
- Conditions
- Osteoporosis
- Interventions
- First Posted Date
- 2005-09-05
- Last Posted Date
- 2013-08-09
- Lead Sponsor
- Chugai Pharmaceutical
- Target Recruit Count
- 1056
- Registration Number
- NCT00144456
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.